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Leukocyte C5a receptor modulation during hemodialysis. Exposure of
blood to hemodialysis (HD) membranes results in the activation of the
complement system. In this study, flow cytometry was used to analyze
the binding of fluoresceinated chemotactic factors (C5a, f-Met-Leu-
Phe-Lys [fMLPL], and casein) and aggregated IgG to PMN and mono-
cytes isolated from normal whole blood following passage through a
hemodialyzer. Analysis of ligand binding by these PMN and monocytes
showed no difference in the binding of casein, fMLPL, or aggregated
IgG throughout the 45 minute procedure. In contrast, a progressive
decrease in the binding of C5a by PMN and monocytes occurred. By 45
minutes, the average percentage of PMN binding C5a had dropped from
95 to 61% and monocytes from 73 to 40%. In additional studies, blood
samples were obtained from chronic renal failure patients undergoing
hemodialysis at four different time intervals during dialysis. Total white
blood cell (WBC) counts showed that the mean WBC count at 30
minutes dropped to 60.9% of the predialysis WBC count, and re-
bounded to 133.8% by two hours and 128.2% by four hours. Analysis of
the binding of C5a, casein, fMLPL, or aggregated IgG by PMN or
monocytes from HD patients indicated there were no significant differ-
ences at the four time intervals studied. When blood samples from
normal subjects or chronic hemodialysis patients were incubated in
vitro with dialysis membrane fibers, a loss of identifiable C5a receptors
was observed on PMN from normal blood, while PMN from HD
patients showed no significant change in the percentage of C5a-
receptor—positive cells. When normal PMN were isolated and resus-
pended in either normal or patient plasma and then exposed to HD
membrane fibers, only cells in normal plasma showed a significant drop
in C5a binding. These studies indicate that C5a receptors on PMN and
monocytes obtained from normal donor blood exposed to dialysis
membranes are specifically blocked or internalized. In contrast, even
though PMN and monocytes from HD patients are continuously ex-
posed to C5a generated during the dialysis procedure, they do not show
a decrease in the binding of C5a. These findings suggest that adaptive
mechanisms function in chronically hemodialyzed patients to modulate
the effects of excessive CSa generation during HD.
Chronic renal failure patients on hemodialysis (HD) have an
enhanced susceptibility to infection which may partially be due
to altered chemotactic ability of their neutrophils (PMN) [1—4].
It has been shown that most dialysis membranes activate the
alternate pathway of complement resulting in the generation of
CSa, a potent chemotactic factor [5]. The generation of C5a in
vivo leads to pulmonary leukostasis, resulting in profound
leukopenia by 15 to 30 minutes after the initiation of dialysis
[6-8]. Within one to two hours after initiating HD, there is
rebound leukocytosis which can be accounted for by a return of
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the white blood cells (WBC) to the circulation from the lungs [7]
and/or bone marrow release of immature (band) neutrophils into
circulation [7, 9—11].
A number of abnormalities have been demonstrated in the
PMN remaining in the peripheral circulation during the dialysis
procedure. These intradialysis PMN have been shown to have:
1) a diminished chemiluminescence response [10, 121; 2) de-
creased H202 secretion [10]; 3) an abnormal in vitro chemotac-
tic response [9, 13]; 4) fewer surface receptors for a formylated
peptide [101; 5) decreased number of circulating Fe-receptor—
bearing PMN [9, 14]; 6) a defective aggregation response [9, 13,
14]; and 7) diminished adherence [9, 141. The altered functional
capabilities of these PMN may contribute to the increased
susceptibility to infection observed in these patients.
Studies by Skubitz and Craddock have shown that granulo-
cytes returning to the circulation after pulmonary leukostasis
are unresponsive to CSades argbut not fMLP, suggesting a down
regulation of the chemotactic receptor [13]. A previous study by
Chenoweth, Cheung and Henderson has shown that chronically
hemodialyzed patients have significantly elevated plasma levels
of C5a even in the predialysis period [15]. Therefore, the
possibility exists that C5a generated during HD may contribute
to the chemotactic unresponsiveness of PMN obtained from
HD patients secondary to decreased availability of C5a recep-
tors.
Although studies on chronic HD patients have consistently
reported decreased PMN chemotactic responsiveness [1, 2] and
activation of complement by hemodialyzers [15—19], direct
evidence for alterations in leukocyte C5a receptors is lacking.
To explore the possibility of chemotactic receptor modulation,
this study was designed to analyze chemotactic receptors for
C5a, casein, and f-met-leu-phe-lys (fMLPL) on PMN and
monocytes from RD patients during the course of dialysis and
from normal control blood following exposure to dialysis mem-
branes.
Methods
Patients
Table 1 shows the clinical and laboratory characteristics of
the 14 chronic hemodialysis patients studied. Blood samples
were obtained at four different time intervals (predialysis and at
intradialysis periods of 30 minutes, two hours, and four hours)
from the afferent (arterial) blood line leading from the patient to
the dialyzer. In some instances blood was also obtained from
the efferent line leading from the dialyzer to the patient.
Complete blood cell counts were done on each sample. The
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Table 1. Clinical and laboratory data of patients studied
Hemodialysis
patients(N = 14)
Age 55.4 4.1
Sex F=7 M=7
Duration of hemodialysis, yrs 4.5 1.0
Total WBC count, 1O3/d 7.12 0.44
Hematocrit, vol % 29.77 2.12
Hemoglobin, gidI 10.10 0.75
Platelet count, 1031p./ 227.50 13.46
BUN, mg/dl 71.50 6.09
Serum creatinine, mgldl 11.97 0.96
Numbers are mean SEM
type of hollow fiber dialyzer varied among the HD patients: four
were dialyzed with regenerated cellulose membanes (C-DAK),
nine with Cupropha& membranes (Terumo [Clirans]), and one
with a cellulose acetate membrane (C-DAK). All HD patients
underwent dialysis for four hours, three times per week, and all
data reported are for the first time use of the dialyzer. None of
the patients studied had clinical evidence of infection at the time
of the study. The Human Research Review Committee at The
University of New Mexico School of Medicine approved the
research proposal, and studies were performed in accord with
an assurance filed with and approved by the Department of
Health and Human Services. Informed consent was obtained
from the participating subjects.
In vitro dialysis system
Peripheral blood (180 ml) was obtained from five normal
donors, anticoagulated with heparin (10 units/mI), and pumped
through one of three types of hemodialyzers (regenerated
cellulose, cellulose acetate, or cuprophane). Dialyzers were
kept at 37°C in a CO2 incubator and the blood was pumped from
a beaker through polyurethane tubing to the dialyzer and
recycled at a rate proportional to the blood exchange rate in
vivo. Dialysate solution was not simultaneously pumped
through the dialyzer. Blood samples were collected at six
different time intervals (0, 5, 10, 20, 30, and 45 minutes)
following contact of the blood with the dialyzer and complete
blood cell counts were done. When the dialyzer was re-used, it
was cleaned and stored in 2% formaldehyde between uses.
Preparation of leukocytes
Leukocytes were prepared from heparinized blood by mixing
the whole blood with an equal volume of Hank's balanced salt
solution (HBSS) (Gibco Laboratories, Grand Island, New
York, USA). Plasmagel (HTI Corp., Buffalo, New York, USA)
(5 ml per 10 ml blood) was added to the suspension and
erythrocytes were allowed to sediment for 30 minutes at 37°C.
The WBC-containing supernatant was then aspirated and cen-
trifuged at 800 x g for 10 minutes, and residual erythrocytes
were lysed with a 20-second, 4°C, distilled H20 treatment, Cells
were washed with HBSS and resuspended to 1 x iO cells/ml in
HBSS. Differential counts were done on each cell preparation
after Wright—staining.
Preparation offluorescein—labeled factors
Fluoresceinated casein (Fi-casein), fluoresceinated C5a
(Fl-C5a), and fluoresceinated fMLPL (F1-fMLPL) were pre-
pared as previously described [20—22]. Fluorescent IgG (Fl-
IgG) was prepared by fluoresceination of 60°C heat—aggregated
human IgG (Fraction II, Miles Laboratories, Elkart, Indiana,
USA [23]. The fluorescein—protein (peptide) ratios were 1 for
F1-C5a, 1 for F1-IMLPL, 2.6 for F1-IgG, and 6 for Fi-casein.
Staining of WBC with fluoresceinated probes and analysis by
flow cytometry
WBC (2 x 106) were stained as a cell pellet with 50 jil of 50
nM Fl-C5a, 65 g Fl-casein, 12.5 tg F1-IgG, or Fl-fMLPL
(titrated to optimal binding concentrations with normal PMN).
These concentrations are all in excess of the amount needed to
obtain optimal binding activity with normal PMN and mono-
cytes [20—22]. In most situations incubation was done at 20°C
for 20 minutes; the cells were washed and resuspended in 0.5 ml
phosphate—buffered saline (PBS), pH 7.2. In some situations,
incubation was done at 40°C. This suspension was immediately
fixed with an equal volume of 2% paraformaldehyde and stored
in the dark at 4°C until analyzed.
The binding of the fluorescent probes was assessed by flow
cytometry using a FACS III fluorescence—activated cell sorter
(Becton—Dickinson, Mountainview, California, USA) inter-
faced with a Digital computer with list—mode data acquisition.
On all samples, 30,000 cells were analyzed using low—for-
ward—angle light scatter, 90° light scatter, and fluorescence
measurements. Using both low—forward—angle scatter and 90°
light scatter, the WBC were characterized as separate popula•
tions of lymphocytes, monocytes, and PMN. The binding of the
fluorescent probes to PMN and monocytes was assessed. The
data are presented as the percentage of cells binding the
fluorescent tigand and the mean channel of fluorescence inten-
sity. The percentage of positive cells was determined by quan-
titating the number of cells in those channels above which 95%
of the unstained control cells reside.
Incubation of whole blood with dialysis membrane fibers
Blood (5 ml) obtained from five HD patients (in the predial-
ysis period) and five normal controls was incubated for 15
minutes at 37°C with 0.5 g of hollow—fiber regenerated—cellulose
membrane obtained from a hemodialyzer. Blood was decanted
and WBC were isolated and analyzed for the binding of the
fluorescent chemotactic factors C5a and fMLPL. In some
experiments PMN (1 x l0) were isolated from four different
normal control subjects, resuspended in 3 ml of normal or HD
patient plasma, and incubated with 0.3 g HD membrane fibers.
The cells were subsequently washed with HBSS and analyzed
for binding of FL-C5a and FL-fMLPL.
Plasma C3a assay
'Cuprophan is the tradename applied to cuprophane membranes
manufactured by Membrana AG (formerly Enka AG). Terumo (Clirans)
dialyzers utilize Cuprophan membranes.
Plasma (2 ml) obtained from five HD patients (in the predi-
alysis period) and four normal controls was incubated for 15
minutes at 37°C with 0.3 g of hollow—fiber regenerated-cellulose
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membrane obtained from a hemodialyzer. The plasma was
decanted and plasma concentrations of C3a antigen were deter-
mined by radioimmunoassay (RIA) procedures as previously
described 24].
Data analysis
Data was analyzed using unpaired and paired t-tests and
analysis of variance (ANOVA) using a statistical analysis
system (SAS) program. Significance levels are indicated
throughout the manuscript where appropriate.
Results
Analysis of receptors for chemotactic factors and IgG on
leukocytes from normal blood pumped through a
hemodialyzer
To study the specific effects of the dialysis membrane on
WBC receptor modulation, 180 ml of peripheral blood from five
different normal controls was pumped through various kinds of
hemodialyzers, including two regenerated cellulose, one cellu-
lose acetate, and two cuprophane membranes. Blood samples
were collected at six different time intervals (0, 5, 10, 20, 30,
and 45 minutes) and WBC were separated. In addition, WBC
counts and differentials were done on the blood samples at 0,
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Fig. 2. Peripheral whole blood obtained from 5 different normal con-
trols was pumped through 3 types of hemodialyzers including 2 regen-
erated cellulose, I cellulose acetate, and 2 cuprophane. Symbols are:
(A) C5a; (•) casein; (0) IgG; and (A) fMLPL. Samples were taken at
the various time intervals as indicated on the horizontal axis. The sem
was less than 2% of the mean in all cases.
10, 20, and 45 minutes. The five controls had a mean WBC
count of 6.36 x 103/pi at 0 minutes which decreased by 13.5%
at 10 minutes, 19.5% at 20 minutes, and 21.7% at 45 minutes
(Fig. 1). The changes in WBC were primarily due to a decrease
in the number of PMN which paralleled the decrease in total
WBC. The absolute number of lymphocytes stayed the same
throughout the procedure.
The results of studies for ligand binding by the five normal
controls showed no difference in the percentage of PMN or
monocytes binding casein, fMLPL, or aggregated IgG through-
out the course of exposure to the dialysis membranes (Fig. 2).
In contrast, the percentage of C5a-receptor—positve PMN and
monocytes progressively decreased throughout the course of
time the cells were passed through the dialyzer, with an average
decrease of 34% for PMN and 33% for monocytes by 45 minutes
(Fig. 2), and an average decrease in the mean channel of
fluorescence intensity of 42% for PMN and 44% for monocytes.
The average mean channel of fluorescence for PMN binding
C5a decreased from 60.1 4.3 at 0 minutes to 34.5 4.2 at 45
minutes (P < 0.01), and for monocytes decreased from 18.2
2.8 at 0 minutes to 10.2 2.1 at 45 minutes (P < 0.05).
Histogram analysis of the fluorescence intensity showed a
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Fig. 1. Total WBC counts of blood samples obtained at four different
time intervals from five different normal subjects during the pumping of
their blood through various hemodialyzers. Symbols are: (0) (I)
cuprophane; (U) (LI) regenerated cellulose; and (A) cellulose acetate.
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Fig. 3. Peripheral blood from 2 normal controls was pumped through
2 different regenerated cellulose hemodialyzers at 3 separate but
consecutive uses of the dialyzer. In between uses the dialyzer was
cleaned and stored in formaldehyde. Following WBC separation from
whole blood, binding studies of Fl-C5a to PMN and monocytes were
done. The percentage of cells binding F1-C5a was calculated, and the
results are plotted as the mean percentage of positive cells from the 2
different controls. Symbols are: (A) 1st use; (S) 2nd use; (0) 3rd use.
symmetric distribution of both PMN and monocytes. When
analysis of C5a binding was done at 4°C as compared to 20°C as
was used in the experiments described here, there was a 10%
decrease in C5a binding for normals and a 9% decrease for HD
patients. Neither of these decreases were significant (P> 0.19),
indicating that internalization of C5a was not a major compo-
nent of the observed fluorescence.
For two of the normal controls, the regenerated cellulose
dialyzer was cleaned and reused at two-week intervals for a
total of three consecutive uses. With reuse the drop in the
percentage of C5a-receptor—positive PMN and monocytes was
diminished as compared to that found with the first use of the
dialyzer (Fig. 3). By 45 minutes, there was an average decrease
of 34% (P < 0.001) for PMN and 43% (P < 0.001) for monocytes
with the first use, and 26% (P < 0.01) for PMN and 28% (P <
0.01) for monocytes with the second use. By the third use, the
percentage of C5a-receptor—positive PMN and monocytes did
not differ significantly from 0 to 45 minutes. The changes in
binding were also reflected in a decrease in the mean channel of
fluorescence intensity which paralleled shifts in the percentage
of positive cells.
Changes in WBC counts during the course of hemodialysis
Fourteen patients were initially studied, and blood samples
were taken from the arterial line leading from the patient to the
dialyzer at four different time intervals (0, 1/2, 2, 4 hours).
These time intervals were chosen to represent different phases
in WBC dynamics during the course of dialysis. By 30 minutes,
the mean WBC count was 60.9% (P < 0.003) of the predialysis
WBC count, by two hours it was 133.8% (P < 0.01), and by four
hours it was 128.2% (P < 0.02) of the predialysis WBC count
(Fig. 4). The alterations in WBC counts were primarily due to
changes in the number of PMN in the circulation. By 30
minutes, the mean PMN count was 68.3% of the predialysis
value, 138.4% by two hours, and 130.2% by four hours. The
mean percentage of bands predialysis was 1.3% and increased
to 4.3% at 30 minutes, 9.2% at two hours and to 10.3% by four
hours. The number of monocytes paralleled the changes in
neutrophil counts during the dialysis procedure while the abso-
lute number of lymphocytes, basophils, and eosinophils did not
vary significantly throughout the HD procedure.
Comparison of chemotactic factor and IgG binding to
leukocytes during the course of hemodialysis
Chemotactic factor and aggregated IgG binding to PMN and
monocytes was evaluated in six HD patients throughout the
course of hemodialysis. All patients used cuprophane dialyzers
and these studies were performed during the first use of the
dialyzer. The results of these experiments indicated there was
no significant difference in the percentage of PMN binding
casein, fMLPL, or aggregated IgG at the four time intervals
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Fig. 4. Total WBC counts of 10 ddferent patients at 4 different time
intervals during the course of hemodialysis. The mean (± SEM) WBC
count predialysis was 7.2 0.49 as compared to 4.39 0.69 at 30
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Intradialysis
Fig. 5. Comparison of the percentage of PMN binding fluoresceinated
casein, JMLPL, or aggregated IgG in 6 different patients using
cuprophane dialyzers over the course of hemodialysis. The results for
each patient are shown at 4 different time intervals during hemodialysis.
The mean results are, respectively for casein 90, 89, 90, 90; fMLPL 88,
86, 90, 88; and aggregated IgG 91, 88, 93, 92.
studied (Fig. 5). Similar results were obtained when comparing
the mean channel of fluorescence intensity for each factor at the
four different time intervals. There were no distinct subsets of
either neutrophils or monocytes as determined by histogram
analysis at any of these time intervals. As compared to the
predialysis period, at 30 minutes there was slight, but statisti-
cally insignificant, decrease in the percentage of positive PMN
with values equal to or exceeding predialysis levels by two
hours. This decrease at 30 minutes corresponds to the
intradialysis leukopenic period described previously. Although
there was no significant difference in the average percentage of
monocytes from the six patients which bound casein, fMLPL,
or aggregated IgG at the four time intervals studied, two
patients did show a slight but insignificant decrease (P 0.11)
in fMLPL-receptor—positive monocytes at 30 minutes into
dialysis as compared to the predialysis period (Fig. 6). Similar
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Fig. 6. Comparison of the percentage of monocytes binding
fluoresceinated casein, fMLPL, or aggregated IgG in 6 different
patients using cuprophane dialyzers over the course of hemodialysis.
The mean results are, respectively for casein 94, 91, 94, 91; fMLPL 86,
79, 90, 88; and aggregated IgG 95, 90, 93, 90.
changes were also found in the mean channel of fluorescence
intensity.
As compared to the other factors, the binding of F1-C5a
showed a slightly different pattern with both PMN and
monocytes (Fig. 7). In contrast to the slight decrease at 30
minutes with PMN and monocytes which bound casein,
fMLPL, and aggregated IgG, in four patients there was a slight
but insignificant increase in percentage of C5a-receptor—
positive PMN, while one patient stayed the same and one
(patient J) showed a decrease (from 88 to 76%). Analysis of the
C5a-receptor--positive monocytes throughout the dialysis treat-
ment indicated that at 30 minutes, four patients showed a
decrease (average decrease of 12.7% with patient J showing a
further drop at two hours), one patient stayed the same, and one
patient showed an increase (from 38 to 48%). Patient J's
predialysis values for C5a-positive monocytes at 81% far ex-
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Fig. 7. Comparison of the percentage of PMN or monocytes binding
F1-C5a in 6 dy'ferent patients using cuprophane dialyzers over the
course of hemodialysis. The mean results for PMN are 83, 84, 84, and
83, and for monocytes 48, 49, 41, and 46. The average mean channel of
fluorescence at the 4 different time intervals for PMN is 420, 40.2, 40.7,
38.2 and for monocytes 16.8, 15.0, 12.7, 13.0.
ceeded the average of 42% for the other five patients and was
close to that seen with normal cells. It is of interest to note that
patient J had been on hemodialysis for a period of only two
months at the time of this initial study compared to 1/2 to nine
years for the other patients. When she was followed up three
months later, she showed no difference between the percentage
of C5a-receptor—positive PMN (74%) in the predialysis period
as compared to the 30-minute intradialysis period, and there
was only a slight but insignificant decrease (from 43 to 40%) in
the percentage of C5a-positive monocytes at 30 minutes as
compared to the predialysis period.
To explore whether there was a difference in C5a-recep-
tor—positive PMN between arterial (patient to dialyzer) and
venous (dialyzer to patient) blood, whole blood samples were
collected at 0-, 10-, and 30-minute intervals from both sites in
three different patients who had been on HD for more than one
year. The WBC were isolated and analyzed for binding of
F1-C5a. We found no significant difference in the percentage of
C5a-positive PMN at any of these three time intervals when
comparing cells isolated from arterial or venous blood (data not
shown).
Analysis of chemotactic receptor binding of HD and normal
PMN from whole blood incubated with dialysis membrane
fibers
To determine if the differences observed in PMN C5a recep-
tor modulation between normal blood exposed in vitro to
dialysis membranes and blood obtained from patients during
hemodialysis reflected an intrinsic difference between patient
and normal controls, whole blood (5 ml) obtained from five
long—term HD patients (in the predialysis period) and five
normal controls was incubated for 15 minutes with 0.5 g of HD
hollow membrane fibers from a regenerated cellulose dialyzer.
WBC were isolated, cell counts were done, and PMN were
analyzed for the binding of Fl-C5a and Fl-fMLPL. There was
less than a 10% decrease in the WBC counts of the blood
samples after incubation with the fibers. In the controls, the
mean (± sEM) percentage of PMN binding Fl-C5a decreased
from 91.6 2.3 to 72.2 3.4 (P < 0.001 by paired t-test) (Fig.
8). These differences in C5a binding were also reflected in the
changes in the mean channel of fluorescence. In contrast, the
mean (± sEM) percentage of PMN from the five HD patients
that bound Fl-C5a did not decrease significantly and went from
73 2.13to71.2 2.84(P0.86bypairedt-test). Forboththe
normal controls and HD patients, there was no significant
difference in the mean percentage or fluorescence intensity of
PMN which bound F1-fMLPL before and after fiber incubation.
In further studies, normal PMN were isolated from four
different normal subjects and resuspended in their own plasma
or plasma from six different HD patients. After these cell—
plasma preparations were exposed to HD membrane fibers,
they were washed and subsequently analyzed for the binding of
FL-C5a and FL-fMLPL. The PMN suspended in normal
plasma had a mean (±sEM) decrease of 21.6 4.3% (P < 0.01)
in C5a-positive cells following fiber incubation compared to a
decrease of 9.2 3.4% (P > 0.42) for the PMN suspended in
patient plasma. There was no significant difference in the mean
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Fig. 8. Comparison of the percentage of C5a and fMLP receptor-
positive PMN from 5 normal controls, no fibers () and 5 HD patients
following incubation of whole blood with regenerated cellulose dialysis
membrane fibers (s). Shown is the mean percentage (± SEM) of PMN
that bound F1-CSa or F1-fMLPL before and after incubation with the
fibers.
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percentage of PMN which bound FL-fMLPL in any PMN-
plasma preparation before or after fiber incubation.
To assure that complement activation occurred in plasma
exposed to dialysis fibers, plasma from five different HD
patients and four different normal subjects was exposed to HD
membrane fibers for 15 minutes at 37°C and subsequently
analyzed by RIA for C3a. There was a significant increase in
C3a levels following incubation of fibers with plasma in both
groups. No difference was observed in the extent of activation
between the two groups. Normal subject plasma C3a levels
increased significantly from a mean of 0.473 0.085 to 0.947
0.073 ig/ml (P <0.02). HD patient plasma C3a levels increased
from 0.675 0.069 to 1.29 0.087 g/ml (P < 0.02).
Discussion
These studies demonstrate that when normal blood is passed
through an in vitro dialysis system, there is a marked drop in the
percentage of PMN and monocytes with identifiable C5a recep-
tors with little or no change in the cells bearing receptors for
fMLPL, casein, or aggregated IgG. It is possible that the loss of
C5a-receptor—bearing PMN and monocytes is attributable to a
loss of cells due to adherence to the membrane. Indeed, by 45
minutes, the total WBC count was decreased by 21.7% as
compared to 0 minutes. However, the decrease in the percent-
age of C5a-receptor—positive cells was 34% for PMN and 33%
for monocytes and exceeds the cell loss. In addition, when
changes in the mean channel of fluorescence intensity was
analyzed, there was a decrease of 42% for PMN and 44% for
monocytes, suggesting that only about half of the original
number of CSa receptors were available to bind Fl-C5a. Fur-
thermore, there was no significant drop in the percentage of
PMN or monocytes bearing receptors for casein, fMLP, or IgG
during this time. Since greater than 90% of PMN have receptors
for all four ligands [20, 21, 25], it seems likely that the decrease
in C5a receptor bearing cells is due to selective block or loss of
these receptors. Although the data suggest that the decrease in
C5a binding reflects an overall block or loss of C5a receptors,
we cannot totally rule out the possibility that cells with a high
density of C5a receptors are selectively lost by adherence.
These results are not unexpected since previous studies have
demonstrated the in vitro potency of dialysis membranes to
activate complement in blood obtained from normal healthy
subjects [8, 18] as well as in vivo in patients on hemodialysis [5,
15—17]. It is clear from the current data that the level of
complement activation and subsequent generation of C5a is
sufficiently high to block C5a receptors in whole blood. Al-
though it has been shown there is continual complement acti-
vation during hemodialysis with the first use of the dialyzer,
with reuse there is substantially less complement activation and
C5a generation [15—19]. This decreased activation is probably
due to deposition of C3b or C3b-derived fragment on the
cellulose membrane surfaces which effectively masks comple-
ment—activating sites [19]. The results presented here demon-
strate that with the reuse of the dialyzers in our in vitro system
there is less blocking of C5a receptors on PMN and monocytes,
which is consistent with previous results.
A previous study by Van Epps and Chenoweth demonstrated
that Fl-C5a was bound by an average of 93% of human PMN
and 68% of monocytes [21]. Subsequently, we showed that
PMN and monocytes from HD patients (in the predialysis
period) have significantly reduced ability to bind Fl-C5a [25].
The average percentage (± SEM) of cells that bound C5a was
72.9 3.8 for PMN and 54.6 4.5 for monocytes. These
findings with C5a contrasted with the other factors studied
where there is no difference between the controls and HD
patients in the percentage of PMN or monocytes binding casein,
fMLPL, or aggregated IgG. These results were also verified in
the study presented here.
In the current study, serial analysis during the course of HD
indicated that there was no significant difference in the percent-
age of PMN or monocytes binding fluoresceinated C5a, casein,
fMLPL, or aggregated Igo at the four different time intervals.
These findings are especially interesting when comparing these
data with the peripheral WBC counts done at the same time
intervals (Fig. 4). In spite of the decrease in circulating PMN at
30 minutes, these PMN were as capable of binding C5a as the
PMN in the predialysis period. In addition, at two hours and
four hours when there is rebound leukocytosis, the circulating
PMN and monocytes show no difference in their chemotactic
factor—binding capabilities. There was a slight but insignificant
decrease in positive cells for casein, fMLPL, and aggregated
IgG at 30 minutes with a return to predialysis levels by two
hours. This slight decrease at 30 minutes may be secondary to
the loss of some receptor—bearing cells due to pulmonary
leukostasis. At the 15 to 30-minute intradialysis period, previ-
ous investigators have shown 27% fewer PMN receptors for the
formylated peptide N-formyl-Nle-Leu-Phe-Nle-Tyr-Lys [10]
and a decreased number of circulating PMN capable of forming
Fc rosettes [9, 14] as compared to PMN from the same patients
in the predialysis period. In addition to using a different assay
system, these three studies used PMN isolated by Ficoll—Hy-
paque technique. A previous study by this lab has shown that
after the initiation of HD, Ficoll—Hypaque preparation of PMN
from blood samples is not an appropriate method to isolate
PMN, since PMN responding to C5a decrease in density and
appear with the lower density mononuclear cells [26]. Thus, the
cell pellets of the previous studies would not be representative
of the total population of PMN. Prior to our realization of this
problem, binding studies done using PMN obtained from the
cell pellet of Ficoll—Hypaque—separated blood from eight HD
patients indicated that at 30 minutes intradialysis as compared
to the predialysis values, there were 45.2% fewer C5a-re-
ceptor—positive PMN and 49.5% fewer casein receptor—positive
PMN. Thus, the previous postulation that there is a "defec-
tive" population of PMN circulating during dialysis may in part
reflect the method of cell separation.
Although we found little difference in the average percentage
of receptor—bearing cells during dialysis, the one exception to
this was patient J who had been on HD for two months while
the other patients had been on HD for more than one year. In
this patient the initial level of C5a binding was more like normal
control cells, and compared to the predialysis period there was
a decrease in the percentage of C5a-positive PMN and mono-
cytes at 30 minutes which remained throughout the rest of
dialysis, Based on our in vitro studies with normal blood, this
was the finding we had expected with all patients, since it
seemed that increased C5a generation during dialysis would
block C5a receptors. These data indicate that with long—term
hemodialysis there are marked changes in the expression of C5a
receptors.
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There are several possible explanations for the differences
between the findings for patients on HD and the in vitro dialysis
system. One explanation may be that there are alterations in
C5a metabolism. Although there is evidence for enhanced
complement activation during dialysis, significantly increased
levels of plasma C5a in arterial blood samples have not been
found during the course of HD [15, 16, 18]. It is known that C5a
is quickly bound by PMN and monocytes and rapidly metabo-
lized (half—life of less than two minutes) and cleared from
circulation [27, 28]. Furthermore, serum carboxypeptidase rap-
idly cleaves the terminal arginine from C5a, greatly reducing its
chemotactic and binding activity. A recent study by Hakim,
Fearon and Lazarus indicated that there is enhanced clearance
of complement products when patients were recurrently dia-
lyzed with new cuprophane or cellulose acetate membranes
[16]. Thus, it is feasible that C5a would be rapidly removed or
inactivated in vivo and would not effectively block C5a recep-
tors on WBC to the same degree as observed in the in vitro
system where there is no clearance mechanism and no other
cells for C5a to bind to other than the WBC in the whole blood
sample.
Another explanation relates to the possible production of a
serum chemotactic factor inhibitor (CFI) that could rapidly
catabolize or inactivate C5a. McCormick et al found signifi-
cantly increased CFI activity after 15 minutes of hemodialysis
[29]. Goldblum, Van Epps and Reed also reported CFI activity
in the serum of HD patients who had been on dialysis for over
three months [30]. Such an inhibitor could explain our findings
with patient J who had decreased C5a-positive cells after the
initiation of dialysis when tested at two months, but by five
months there was no difference between the predialysis and
intradialysis values. The presence of CFI could be responsible
for the failure of PMN and monocytes from RD patients in our
study to show significant down—regulation of C5a receptors
during the course of dialysis, since CFI would serve to regulate
the level of active CSa.
The results presented here also suggest the presence of a C5a
inhibitor in HD patients. When blood from a normal donor was
incubated in vitro with dialysis membrane fibers there was a
significant decrease in the C5a receptor—positive PMN follow-
ing this incubation. This contrasted with the HD patient blood
which showed no significant difference in the percentage of C5a
receptor—positive PMN following a similar incubation. These
differences between patient and control blood occurred in spite
of equivalent complement activation. In addition, when normal
cells were placed in HD patient plasma and incubated with RD
membrane fibers, there was no significant loss of C5a receptors.
These results imply that chronic use of hemodialyzers may
modify the response of the patient to dialyzer—stimulated com-
plement activation and C5a generation.
Another explanation relates to the possibility that PMN and
monocytes decrease their responsiveness to CSa binding as an
adaptive measure to compensate for chronic CSa exposure.
This adaptation may take place at the cellular level and occur in
addition to regulation by a plasma factor. It is also possible that
the differences in C5a binding by normal cells exposed to
dialysis membranes in vitro, and that occurring in cells from
patients during dialysis may be attributed to the methodologic
differences. Although ethical and technical limitations require
that the study was performed in the manner described, it is
possible that the differences in methodology between the in
vitro dialysis system with normal human blood and actual
hemodialysis may influence the results of C5a binding.
In summary, these studies show that PMN and monocytes
obtained from normal blood pumped through hemodialyzers
have a progressive drop in identifiable C5a receptors but no
change in receptors for casein, fMLPL, or aggregated IgG over
the same time period. In contrast, peripheral PMN and
monocytes from chronic renal failure patients on RD show no
difference in CSa-, casein-, fMLPL-, or aggregated-IgG-recep-
tors during the course of RD as compared to the predialysis
period. Although C5a has been shown to be continuously
generated during the course of RD, these patients show no
modulation of their C5a receptors during the course of RD or
when their whole blood is exposed to dialysis membrane fibers.
These findings suggest there are regulatory mechanisms func-
tioning in chronically hemodialyzed patients to protect them
from the adverse effects of excessive C5a generation during
RD. Although this may be an advantage during dialysis, it may
also be detrimental to host defense by preventing the normal
function of C5a in an inflammatory response, thereby enhancing
the patient's susceptibility to infection.
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